BIOMAT Database Logo BIOMAT Database Logo

PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. 2000

M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Institute of Molecular Oncology, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.

PKC is activated on the cell membrane by phospholipids, thereby transducing signals to intracellular pathways. We provide here another function of PKC, namely, regulating cell cycle by interaction with the cyclin E/cdk2/p21 complex. Among the 10 isoforms of PKC, PKCeta is predominantly expressed in squamous cell epithelia and induces terminal differentiation of keratinocytes. PKCeta that is endogenously expressed or overexpressed was found to associate with the cyclin E/cdk2/p21 complex in keratinocytes of mice and humans. Requirement of a possible adaptor protein to the binding was suggested by the reconstitution of PKCeta and the cyclin E/cdk2/p21 complex which were prepared from human keratinocytes or Sf9 insect cells. Colocalization of PKCeta with cdk2 and cyclin E was observed in the cytoplasm, particularly in the perinuclear region. p21 was phosphorylated in the complex in a PKC-activator dependent manner. Association of PKCeta with cdk2 resulted in marked inhibition of cdk2-kinase activity when measured by phosphorylation of Rb. Dominant negative PKCeta associated with the cyclin E/cdk2/p21 complex, but caused a little inhibition of cdk2 kinase activity. Among the known regulatory mechanisms of cdk2 activity, dephosphorylation of Thr160 was demonstrated. Oncogene (2000) 19, 6334 - 6341.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010769 Phosphothreonine The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes. Threonine Phosphate,Phosphate, Threonine
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
PKCeta associates with cyclin E/Cdk2 complex in serum-starved MCF-7 and NIH-3T3 cells.
May 2003, Experimental cell research,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
July 1997, Molecular and cellular biology,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis.
June 2006, FEBS letters,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.
August 2001, The Journal of biological chemistry,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Human p55(CDC)/Cdc20 associates with cyclin A and is phosphorylated by the cyclin A-Cdk2 complex.
February 2000, Biochemical and biophysical research communications,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
December 1996, Molecular and cellular biology,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
May 1996, Oncogene,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
April 1996, European journal of biochemistry,
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Dependence of cyclin E-CDK2 kinase activity on cell anchorage.
January 1996, Science (New York, N.Y.),
M Kashiwagi, and M Ohba, and H Watanabe, and K Ishino, and K Kasahara, and Y Sanai, and Y Taya, and T Kuroki
Casein kinase 2 associates with and phosphorylates dishevelled.
June 1997, The EMBO journal,
Copied contents to your clipboard!